1,671
Participants
Start Date
August 1, 2018
Primary Completion Date
January 16, 2020
Study Completion Date
January 20, 2020
Sulopenem-Etzadroxil/Probenecid
Treatment of uncomplicated urinary tract infection
Ciprofloxacin
Treatment of uncomplicated urinary tract infection
Medical Facility, Brooklyn
Medical Facility, Washington D.C.
Medical Facility, Raleigh
Medical Facility, Myrtle Beach
Medical Facility, Easley
Medical Facility, Lancaster
Medical Facility, Norcross
Medical Facility, Atlanta
Medical Facility, Perry
Medical Facility, Edgewater
Medical Facility, Ormond Beach
Medical Facility, Hialeah
Medical Facility, Miami
Medical Facility, Miami
Medical Facility, Miami
Medical Facility, Miami
Medical Facility, Miami
Medical Facility, Palmetto Bay
Medical Facility, Miami
Medical Facility, Doral
Medical Facility, Miami Springs
Medical Facility, Miami
Medical Facility, Miami
Medical Facility, Lauderdale Lakes
Medical Facility, St. Petersburg
Medical Facility, Clearwater
Medical Facility, Winter Haven
Medical Facility, Bradenton
Medical Facility, New Port Richey
Medical Facility, Birmingham
Medical Facility, Metairie
Medical Facility, New Orleans
Medical Facility, Lake Charles
Medical Facility, Hugo
Medical Facility, Carrollton
Medical Facility, Plano
Medical Facility, Dallas
Medical Facility, Houston
Medical Facility, Houston
Medical Facility, Sugar Land
Medical Facility, Pearland
Medical Facility, Corpus Christi
Medical Facility, Austin
Medical Facility, Austin
Medical Facility, Bountiful
Medical Facility, South Jordan
Medical Facility, Salt Lake City
Medical Facility, Salt Lake City
Medical Facility, St. George
Medical Facility, Phoenix
Medical Facility, Tolleson
Medical Facility, Las Vegas
Medical Facility, Las Vegas
Medical Facility, Los Angeles
Medical Facility, Cerritos
Medical Facility, Sylmar
Medical Facility, Chula Vista
Medical Facility, La Mesa
Medical Facility, San Diego
Medical Facility, Fullerton
Lead Sponsor
Iterum Therapeutics, International Limited
INDUSTRY